Jie‐Fei Cheng

2.8k total citations
67 papers, 2.1k citations indexed

About

Jie‐Fei Cheng is a scholar working on Organic Chemistry, Molecular Biology and Biotechnology. According to data from OpenAlex, Jie‐Fei Cheng has authored 67 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Organic Chemistry, 21 papers in Molecular Biology and 19 papers in Biotechnology. Recurrent topics in Jie‐Fei Cheng's work include Marine Sponges and Natural Products (17 papers), Synthetic Organic Chemistry Methods (9 papers) and Metabolism and Genetic Disorders (8 papers). Jie‐Fei Cheng is often cited by papers focused on Marine Sponges and Natural Products (17 papers), Synthetic Organic Chemistry Methods (9 papers) and Metabolism and Genetic Disorders (8 papers). Jie‐Fei Cheng collaborates with scholars based in United States, China and Japan. Jie‐Fei Cheng's co-authors include Yasushi Ohizumi, Jun’ichi Kobayashi, Takuma Sasaki, Shosuke Yamamura, Alex M. Nadzan, Thomas Arrhenius, Yoshimasa Hiratå, Masami Ishibashi, Hideshi Nakamura and Shigeo Nozoe and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Circulation Research.

In The Last Decade

Jie‐Fei Cheng

66 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie‐Fei Cheng United States 28 1.1k 626 475 320 286 67 2.1k
George A. Doss United States 29 681 0.6× 876 1.4× 91 0.2× 497 1.6× 95 0.3× 95 2.6k
K.C. Nicolaou United States 22 1.3k 1.2× 518 0.8× 107 0.2× 379 1.2× 72 0.3× 38 1.8k
Bruce D. Roth United States 30 1.4k 1.3× 906 1.4× 230 0.5× 325 1.0× 237 0.8× 61 2.6k
Samuel Chackalamannil United States 24 848 0.8× 504 0.8× 68 0.1× 137 0.4× 89 0.3× 75 1.7k
Joseph P. Marino United States 34 2.5k 2.3× 604 1.0× 106 0.2× 161 0.5× 65 0.2× 112 3.2k
Marinella Roberti Italy 35 1.5k 1.4× 1.6k 2.6× 52 0.1× 475 1.5× 383 1.3× 111 3.6k
David A. Claremon United States 24 992 0.9× 538 0.9× 71 0.1× 183 0.6× 35 0.1× 50 1.7k
Renata M. Oballa Canada 24 720 0.7× 899 1.4× 257 0.5× 143 0.4× 281 1.0× 42 1.8k
Howard E. Morton United States 24 1.4k 1.3× 599 1.0× 114 0.2× 266 0.8× 45 0.2× 53 1.9k
Paul Erhardt United States 28 816 0.8× 901 1.4× 37 0.1× 212 0.7× 103 0.4× 113 2.3k

Countries citing papers authored by Jie‐Fei Cheng

Since Specialization
Citations

This map shows the geographic impact of Jie‐Fei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie‐Fei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie‐Fei Cheng more than expected).

Fields of papers citing papers by Jie‐Fei Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie‐Fei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie‐Fei Cheng. The network helps show where Jie‐Fei Cheng may publish in the future.

Co-authorship network of co-authors of Jie‐Fei Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jie‐Fei Cheng. A scholar is included among the top collaborators of Jie‐Fei Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie‐Fei Cheng. Jie‐Fei Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suvannasankha, Attaya, Jonathan L. Kaufman, Ashraf Badros, et al.. (2025). Safety and efficacy of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma: Results from the phase 1b MagnetisMM-30 trial. Blood. 146(Supplement 1). 100–100.
2.
Tang, Ling, et al.. (2024). Cryoablation versus microwave ablation in the treatment of hepatocellular carcinoma: A Systematic Review and meta-analysis. Asian Journal of Surgery. 48(3). 1626–1633. 2 indexed citations
3.
Cheng, Jie‐Fei, et al.. (2024). Meta-analysis of transarterial chemoembolization combined with cryoablation vs transarterial chemoembolization alone for ≥ 5 cm hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 16(6). 2793–2803. 1 indexed citations
4.
Zhao, Jiaying, Feng Wang, Jianwei Zhang, et al.. (2021). A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism. European Journal of Medicinal Chemistry. 217. 113379–113379. 40 indexed citations
5.
Cheng, Jie‐Fei, et al.. (2020). Asymmetric Synthesis of Prodrug Nucleotides (ProTides): Construction of the P-Stereogenic Centers. Chinese Journal of Organic Chemistry. 40(10). 3237–3237. 3 indexed citations
6.
Xu, Yue & Jie‐Fei Cheng. (2016). Small molecule drug development based on derivatization of natural products. Chinese Science Bulletin (Chinese Version). 62(9). 908–919. 3 indexed citations
7.
Zhou, Jian‐Liang, Jingjing An, Ping Li, et al.. (2009). Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography–mass spectrometry for solution-based ligand screening against multiple proteins. Journal of Chromatography A. 1216(12). 2394–2403. 25 indexed citations
8.
Cheng, Jie‐Fei & R M Jack. (2008). CCR1 antagonists. Molecular Diversity. 12(1). 17–23. 28 indexed citations
9.
Cheng, Jie‐Fei, James Zapf, Tsuyoshi Ogiku, et al.. (2008). Combination of Virtual Screening and High Throughput Gene Profiling for Identification of Novel Liver X Receptor Modulators. Journal of Medicinal Chemistry. 51(7). 2057–2061. 10 indexed citations
10.
Wallace, D. Michael A., Masayuki Haramura, Jie‐Fei Cheng, Thomas Arrhenius, & Alex M. Nadzan. (2007). Novel trifluoroacetophenone derivatives as malonyl-CoA decarboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(4). 1127–1130. 8 indexed citations
11.
Bakir, Farid, Trang Nguyen, Ila Sircar, et al.. (2007). Discovery and structure–activity relationship studies of indole derivatives as liver X receptor (LXR) agonists. Bioorganic & Medicinal Chemistry Letters. 17(12). 3473–3479. 7 indexed citations
12.
Cheng, Jie‐Fei, Yujin Huang, Masahiro Nishimoto, et al.. (2006). Discovery of Potent and Orally Available Malonyl-CoA Decarboxylase Inhibitors as Cardioprotective Agents. Journal of Medicinal Chemistry. 49(14). 4055–4058. 40 indexed citations
13.
Konski, André, John Hoffman, Oleh Haluszka, et al.. (2005). Can Molecular Imaging Predict Response to Preoperative Chemoradiation in Patients with Rectal Cancer? A Fox Chase Cancer Center Prospective Experience. Seminars in Oncology. 32(6 Suppl 9). 63–67. 16 indexed citations
14.
Scott, William K., Gary M. Freedman, André Konski, et al.. (2005). Morbidity and Mortality are not Increased After Induction Chemoradiotherapy Followed by Esophagectomy in Patients With Esophageal Cancer. Seminars in Oncology. 32(6 Suppl 9). 16–20. 36 indexed citations
15.
Cheng, Jie‐Fei. (2004). Rosuvastatin in the management of hyperlipidemia. Clinical Therapeutics. 26(9). 1368–1387. 52 indexed citations
16.
Reszko, Aneta E., Takhar Kasumov, France David, et al.. (2004). Regulation of Malonyl-CoA Concentration and Turnover in the Normal Heart. Journal of Biological Chemistry. 279(33). 34298–34301. 32 indexed citations
17.
Zhou, Demin, Steven J Brown, M. R. PENA, et al.. (2004). Expression, purification, and characterization of human malonyl-CoA decarboxylase. Protein Expression and Purification. 34(2). 261–269. 18 indexed citations
18.
Cheng, Jie‐Fei, Mi Chen, David R. Wallace, et al.. (2004). Discovery and structure–activity relationship of coumarin derivatives as TNF-α inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(10). 2411–2415. 44 indexed citations
19.
Kobayashi, Jun’ichi, Jie‐Fei Cheng, Hiroshi Nakamura, et al.. (1991). Structure and stereochemistry of brianolide, a new antiinflammatory diterpenoid from the Okinawan gorgonianBriareum sp.. Cellular and Molecular Life Sciences. 47(5). 501–502. 13 indexed citations
20.
Kobayashi, Jun’ichi, Masashi Tsuda, Masami Ishibashi, et al.. (1991). Cystodytins D-I, New Cytotoxic Tetracyclic Aromatic Alkaloids from the Okinawan Marine Tunicate Cystodytes dellechiajei. Journal of Natural Products. 54(6). 1634–1638. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George A. Doss Breakdown of academic impact, for papers by K.C. Nicolaou Breakdown of academic impact, for papers by Bruce D. Roth Breakdown of academic impact, for papers by Samuel Chackalamannil Breakdown of academic impact, for papers by Joseph P. Marino Breakdown of academic impact, for papers by Marinella Roberti Breakdown of academic impact, for papers by David A. Claremon Breakdown of academic impact, for papers by Renata M. Oballa Breakdown of academic impact, for papers by Howard E. Morton Breakdown of academic impact, for papers by Paul Erhardt
Rankless by CCL
2026